Briviact Intravenous and Protonix Tablets
Determining the interaction of Briviact Intravenous and Protonix Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:According to the manufacturer, brivaracetam is a weak inhibitor of CYP450 2C19 in vitro and is not expected to cause significant inhibition of CYP450 2C19 in humans. No precaution is necessary when brivaracetam is coadministered with CYP450 2C19 substrates.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Briviact (brivaracetam)." UCB Pharma Inc, Smyrna, GA.
Generic Name: brivaracetam
Brand name: Briviact
Synonyms: Briviact
Generic Name: pantoprazole
Brand name: Protonix, Protonix IV
Synonyms: Pantoprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Briviact Intravenous-Protopam
- Briviact Intravenous-Protopam Chloride
- Briviact Intravenous-Protophylline Alcohol And Sugar Free
- Briviact Intravenous-Protriptyline
- Briviact Intravenous-Protriptyline Hydrochloride
- Briviact Intravenous-Protyl Ag
- Protonix Tablets-Brodalumab
- Protonix Tablets-Brodalumab Subcutaneous
- Protonix Tablets-Brodspec
- Protonix Tablets-Brom Mal Phenyl HCl Dex HBr
- Protonix Tablets-Bromaline
- Protonix Tablets-Bromaline DM